Efficacy of the XEN-Implant in Glaucoma and a Meta-Analysis of the Literature

Background: To assess the efficacy of XEN-implant surgery in patients with glaucoma, and to perform a meta-analysis of previously published results and compare these to our data. Methods: Prospective case-control study, in which all eyes that underwent XEN-implant surgery were included from 2015 onw...

Full description

Bibliographic Details
Main Authors: Huub J. Poelman, Jan Pals, Parinaz Rostamzad, Wichor M. Bramer, Roger C. W. Wolfs, Wishal D. Ramdas
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/5/1118
_version_ 1797412557387988992
author Huub J. Poelman
Jan Pals
Parinaz Rostamzad
Wichor M. Bramer
Roger C. W. Wolfs
Wishal D. Ramdas
author_facet Huub J. Poelman
Jan Pals
Parinaz Rostamzad
Wichor M. Bramer
Roger C. W. Wolfs
Wishal D. Ramdas
author_sort Huub J. Poelman
collection DOAJ
description Background: To assess the efficacy of XEN-implant surgery in patients with glaucoma, and to perform a meta-analysis of previously published results and compare these to our data. Methods: Prospective case-control study, in which all eyes that underwent XEN-implant surgery were included from 2015 onwards. Sub-analyses were performed for eyes that underwent XEN-implant as standalone procedure and as cataract-combined procedure. To compare our results, a systematic review was performed using the Embase, PubMed, Web of Science, and Cochrane database. Meta-analyses were performed by combining data (intraocular pressure (IOP), IOP-lowering medication, and complications) from the retrieved studies. Results: A total of 221 eyes underwent XEN-implant surgery (124 standalone and 97 cataract-combined). The mean ± standard deviation IOP declined from 18.8 ± 6.5 to 13.5 ± 4.3 mmHg at the last follow-up (<i>p</i> < 0.001; 28.9%). Postoperative, no significant differences in IOP or IOP-lowering medication were found between patients with and without combined procedure. Secondary surgeries were performed in 20.8% of eyes, most of them (63.0%) within six months. A meta-analysis of 19 studies retrieved from the systematic review showed a two-years postoperative pooled mean (weighted mean difference) of 14.5 (7.3) mmHg and 1.0 (1.6) for IOP and IOP-lowering medications, respectively (compared to 13.5 (5.3) mmHg and 3.2 (2.4) in the current study). Conclusion: XEN-implant surgery was effective and safe in lowering IOP and the number of IOP-lowering medications. There were no differences between standalone and combined procedures.
first_indexed 2024-03-09T05:04:52Z
format Article
id doaj.art-3af1dff025e146a4bdff34ce739243ab
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-09T05:04:52Z
publishDate 2021-03-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-3af1dff025e146a4bdff34ce739243ab2023-12-03T12:55:55ZengMDPI AGJournal of Clinical Medicine2077-03832021-03-01105111810.3390/jcm10051118Efficacy of the XEN-Implant in Glaucoma and a Meta-Analysis of the LiteratureHuub J. Poelman0Jan Pals1Parinaz Rostamzad2Wichor M. Bramer3Roger C. W. Wolfs4Wishal D. Ramdas5Department of Ophthalmology, Erasmus MC, University Medical Center, 3000 CA Rotterdam, The NetherlandsDepartment of Ophthalmology, Erasmus MC, University Medical Center, 3000 CA Rotterdam, The NetherlandsDepartment of Ophthalmology, Erasmus MC, University Medical Center, 3000 CA Rotterdam, The NetherlandsMedical Library, Erasmus MC, University Medical Center, 3000 CA Rotterdam, The NetherlandsDepartment of Ophthalmology, Erasmus MC, University Medical Center, 3000 CA Rotterdam, The NetherlandsDepartment of Ophthalmology, Erasmus MC, University Medical Center, 3000 CA Rotterdam, The NetherlandsBackground: To assess the efficacy of XEN-implant surgery in patients with glaucoma, and to perform a meta-analysis of previously published results and compare these to our data. Methods: Prospective case-control study, in which all eyes that underwent XEN-implant surgery were included from 2015 onwards. Sub-analyses were performed for eyes that underwent XEN-implant as standalone procedure and as cataract-combined procedure. To compare our results, a systematic review was performed using the Embase, PubMed, Web of Science, and Cochrane database. Meta-analyses were performed by combining data (intraocular pressure (IOP), IOP-lowering medication, and complications) from the retrieved studies. Results: A total of 221 eyes underwent XEN-implant surgery (124 standalone and 97 cataract-combined). The mean ± standard deviation IOP declined from 18.8 ± 6.5 to 13.5 ± 4.3 mmHg at the last follow-up (<i>p</i> < 0.001; 28.9%). Postoperative, no significant differences in IOP or IOP-lowering medication were found between patients with and without combined procedure. Secondary surgeries were performed in 20.8% of eyes, most of them (63.0%) within six months. A meta-analysis of 19 studies retrieved from the systematic review showed a two-years postoperative pooled mean (weighted mean difference) of 14.5 (7.3) mmHg and 1.0 (1.6) for IOP and IOP-lowering medications, respectively (compared to 13.5 (5.3) mmHg and 3.2 (2.4) in the current study). Conclusion: XEN-implant surgery was effective and safe in lowering IOP and the number of IOP-lowering medications. There were no differences between standalone and combined procedures.https://www.mdpi.com/2077-0383/10/5/1118glaucomaintraocular pressureIOP-lowering medicationXEN-implantXEN45gelatin stent
spellingShingle Huub J. Poelman
Jan Pals
Parinaz Rostamzad
Wichor M. Bramer
Roger C. W. Wolfs
Wishal D. Ramdas
Efficacy of the XEN-Implant in Glaucoma and a Meta-Analysis of the Literature
Journal of Clinical Medicine
glaucoma
intraocular pressure
IOP-lowering medication
XEN-implant
XEN45
gelatin stent
title Efficacy of the XEN-Implant in Glaucoma and a Meta-Analysis of the Literature
title_full Efficacy of the XEN-Implant in Glaucoma and a Meta-Analysis of the Literature
title_fullStr Efficacy of the XEN-Implant in Glaucoma and a Meta-Analysis of the Literature
title_full_unstemmed Efficacy of the XEN-Implant in Glaucoma and a Meta-Analysis of the Literature
title_short Efficacy of the XEN-Implant in Glaucoma and a Meta-Analysis of the Literature
title_sort efficacy of the xen implant in glaucoma and a meta analysis of the literature
topic glaucoma
intraocular pressure
IOP-lowering medication
XEN-implant
XEN45
gelatin stent
url https://www.mdpi.com/2077-0383/10/5/1118
work_keys_str_mv AT huubjpoelman efficacyofthexenimplantinglaucomaandametaanalysisoftheliterature
AT janpals efficacyofthexenimplantinglaucomaandametaanalysisoftheliterature
AT parinazrostamzad efficacyofthexenimplantinglaucomaandametaanalysisoftheliterature
AT wichormbramer efficacyofthexenimplantinglaucomaandametaanalysisoftheliterature
AT rogercwwolfs efficacyofthexenimplantinglaucomaandametaanalysisoftheliterature
AT wishaldramdas efficacyofthexenimplantinglaucomaandametaanalysisoftheliterature